homovanillic acid and entacapone

homovanillic acid has been researched along with entacapone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (90.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaakkola, S; Wurtman, RJ1
Lindén, IB; Nissinen, E; Pohto, P; Schultz, E1
Männistö, PT; Tuomainen, P; Tuominen, RK1
Kaakkola, S; Kask, A; Männistö, PT; Törnwall, M; Tuomainen, P1
Illi, A; Keränen, T; Myllylä, VV; Sotaniemi, KA; Suominen, K1
Männistö, PT; Törnwall, M; Tuomainen, P1
Gordin, A; Harjola, VP; Karlsson, M; Keränen, T; Korpela, K; Pentikäinen, PJ; Rita, H; Seppälä, L; Wikberg, T1
Rinne, UK; Ruottinen, HM1
Brannan, T; Prikhojan, A; Yahr, MD1
Forsberg, MM; Huotari, M; Männistö, PT; Savolainen, J1

Trials

2 trial(s) available for homovanillic acid and entacapone

ArticleYear
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease.
    European journal of clinical pharmacology, 1993, Volume: 45, Issue:5

    Topics: Aged; Blood Pressure; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Hemodynamics; Homovanillic Acid; Humans; Levodopa; Middle Aged; Nitriles; Parkinson Disease; Pulse; Respiration

1993
Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced parkinsonian patients.
    Clinical neuropharmacology, 1996, Volume: 19, Issue:3

    Topics: Aged; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agents; Double-Blind Method; Enzyme Inhibitors; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Tyrosine

1996

Other Studies

8 other study(ies) available for homovanillic acid and entacapone

ArticleYear
Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Brain research, 1992, Aug-07, Volume: 587, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Clorgyline; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nitriles; Nitrophenols; Nomifensine; Rats; Rats, Inbred Strains; Selegiline; Tolcapone

1992
Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.
    Naunyn-Schmiedeberg's archives of pharmacology, 1992, Volume: 346, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Duodenum; Erythrocytes; Homovanillic Acid; In Vitro Techniques; Liver; Male; Nitriles; Rats; Rats, Wistar; Tyrosine

1992
Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
    British journal of pharmacology, 1992, Volume: 105, Issue:3

    Topics: Amidines; Animals; Benzophenones; Biogenic Monoamines; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Homovanillic Acid; Hypothalamus; Levodopa; Male; Methyldopa; Nitriles; Nitrophenols; Pyridones; Rats; Rats, Inbred Strains; Tolcapone

1992
Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
    British journal of pharmacology, 1994, Volume: 112, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amidines; Animals; Biogenic Monoamines; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Microdialysis; Neostriatum; Nitriles; Pyridones; Rats; Rats, Wistar; Stereotaxic Techniques; Tryptophan; Tyrosine

1994
Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
    European journal of pharmacology, 1993, Aug-03, Volume: 239, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amidines; Amphetamine; Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Neurons; Nitriles; Nitrophenols; Pimozide; Pyridones; Rats; Rats, Wistar; Tolcapone

1993
The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers.
    Clinical neuropharmacology, 1993, Volume: 16, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Electrocardiography; Half-Life; Homovanillic Acid; Humans; Levodopa; Male; Nitriles; Reference Values; Tyrosine

1993
Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine; Homovanillic Acid; Levodopa; Liver; Male; Nitriles; Rats; Rats, Sprague-Dawley

1997
The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2005, Volume: 24, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Enzyme Inhibitors; Homovanillic Acid; Male; Microdialysis; Nitriles; Nitrophenols; Rats; Rats, Wistar; Solubility; Tolcapone

2005